0001415889-12-000625.txt : 20120501
0001415889-12-000625.hdr.sgml : 20120501
20120501161517
ACCESSION NUMBER: 0001415889-12-000625
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20120427
FILED AS OF DATE: 20120501
DATE AS OF CHANGE: 20120501
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BURKE KIMBERLY A
CENTRAL INDEX KEY: 0001532658
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35218
FILM NUMBER: 12800835
MAIL ADDRESS:
STREET 1: ECHO THERAPEUTICS, INC.
STREET 2: 8 PENN CENTER, 1628 JFK BLVD., STE 300
CITY: PHILADELPHIA
STATE: PA
ZIP: 19103
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Echo Therapeutics, Inc.
CENTRAL INDEX KEY: 0001031927
STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
IRS NUMBER: 411649949
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 8 PENN CENTER
STREET 2: 1628 JFK BLVD, SUITE 300
CITY: PHILADELPHIA
STATE: PA
ZIP: 19103
BUSINESS PHONE: 215-717-4100
MAIL ADDRESS:
STREET 1: 8 PENN CENTER
STREET 2: 1628 JFK BLVD, SUITE 300
CITY: PHILADELPHIA
STATE: PA
ZIP: 19103
FORMER COMPANY:
FORMER CONFORMED NAME: SONTRA MEDICAL CORP
DATE OF NAME CHANGE: 20020702
FORMER COMPANY:
FORMER CONFORMED NAME: CHOICETEL COMMUNICATIONS INC/MN/
DATE OF NAME CHANGE: 20020701
FORMER COMPANY:
FORMER CONFORMED NAME: SONTRA MEDICAL CORP
DATE OF NAME CHANGE: 20020701
4
1
form4-05012012_040508.xml
X0305
4
2012-04-27
0001031927
Echo Therapeutics, Inc.
ECTE
0001532658
BURKE KIMBERLY A
8 PENN CENTER
1628 JFK BLVD, SUITE 300
PHILADELPHIA
PA
19103
false
true
false
false
GENERAL COUNSEL
Common Stock
2012-04-27
4
A
0
37500
0.00
A
250000
D
In accordance with a Restricted Stock Agreement dated April 27, 2012, 25% of the Shares shall vest on each of April 27, 2013, April 27, 2014, April 27, 2015 and April 27, 2016. Notwithstanding the foregoing, (i) all unvested shares shall become fully vested at any earlier time set forth in the Reporting Person's Employment or Change in Control Agreement with the Company (if any) and (ii) all unvested shares shall immediately vest upon the sale of all or substantially all of the assets of the Company or all or substantially all of the outstanding capital stock of the Company in exchange for Liquid Proceeds. As used herein, "Liquid Proceeds" shall mean (a) cash; (b) securities which can be sold immediately on NYSE or NASDAQ; (c) securities which are or will be registered such that they can be sold on NYSE or NASDAQ upon termination of a lock-up period not to exceed 180 days; or (d) or a combination of cash and the foregoing securities.
/s/ Kimberly A. Burke
2012-05-01